Glycogen synthase 2 Polyclonal Antibody, PE-Cy5.5 Conjugated
Product Specifications
Background
Glycogen synthase catalyzes the rate-limiting step in glycogen synthesis. Its activity is regulated by a complex phosphorylation-dephosphorylation mechanism and by allosteric stimulators and inhibitors. Two isozymes of synthase, a skeletal muscle type (Glycogen synthase 1 - GYS1) and a liver type (Glycogen synthase 2 - GYS2), have been identified.
Synonyms
Glycogen starch synthase liver; Glycogen starch synthase liver; EC 2.4.1.11; Glycogen synthase 2 liver; GYS2; GYS2_HUMAN.
Gene ID
2998
Cellular Locus
Cytoplasm
Host
Rabbit
Cross Reactivity
Mouse
Immunogen
621-703/703
Target
Glycogen synthase 2
Clonality
Polyclonal
Isotype
IgG
Conjugation
PE-Cy5.5
Source
KLH conjugated synthetic peptide derived from human Glycogen synthase 2
Applications
WB
Purification
Purified by Protein A.
Excitation Emission
488nm/694nm
Concentration
1µg/µl
Dilution
WB (1:300-5000)
Buffer
Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Modification
Unmodified
Storage Conditions
Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
Gene ID URL
2998
Predicted Cross Reactivity
Human, Rat, Dog, Pig, Horse, Rabbit
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
032337-AP 200 µL
AVPR1B, CT (AVPR1B, AVPR3, VPR3, Vasopressin V1b receptor, AVPR V1b, AVPR V3, Antidiuretic hormone receptor 1b, Vasopressin V3 receptor) (AP) discontinued
Ask
View Details